CN106749527A - 氯噻啉抗体特异性结合的噬菌体展示多肽及其用途 - Google Patents
氯噻啉抗体特异性结合的噬菌体展示多肽及其用途 Download PDFInfo
- Publication number
- CN106749527A CN106749527A CN201611271306.6A CN201611271306A CN106749527A CN 106749527 A CN106749527 A CN 106749527A CN 201611271306 A CN201611271306 A CN 201611271306A CN 106749527 A CN106749527 A CN 106749527A
- Authority
- CN
- China
- Prior art keywords
- phage
- chlorothialine
- polypeptide
- antibody
- phage display
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 43
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 42
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 37
- 101710132601 Capsid protein Proteins 0.000 claims description 5
- 101710094648 Coat protein Proteins 0.000 claims description 5
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 5
- 101710125418 Major capsid protein Proteins 0.000 claims description 5
- 101710141454 Nucleoprotein Proteins 0.000 claims description 5
- 101710083689 Probable capsid protein Proteins 0.000 claims description 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 241001515965 unidentified phage Species 0.000 claims 1
- 238000002823 phage display Methods 0.000 abstract description 23
- 238000001514 detection method Methods 0.000 abstract description 19
- 238000004091 panning Methods 0.000 abstract description 19
- 238000000034 method Methods 0.000 abstract description 14
- 108090000623 proteins and genes Proteins 0.000 abstract description 13
- 238000002965 ELISA Methods 0.000 abstract description 12
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 125000004122 cyclic group Chemical group 0.000 abstract description 8
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 7
- 230000003321 amplification Effects 0.000 abstract description 5
- 239000013612 plasmid Substances 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000009870 specific binding Effects 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 13
- 238000005406 washing Methods 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 9
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 238000003018 immunoassay Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000007790 solid phase Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000002860 competitive effect Effects 0.000 description 4
- 239000012149 elution buffer Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 238000009739 binding Methods 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000037029 cross reaction Effects 0.000 description 3
- 239000002917 insecticide Substances 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 241000353522 Earias insulana Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000005906 Imidacloprid Substances 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000002967 competitive immunoassay Methods 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 2
- 229940056881 imidacloprid Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 108010027338 isoleucylcysteine Proteins 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- IAUSCRHURCZUJP-CIUDSAMLSA-N Ala-Lys-Cys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CS)C(O)=O IAUSCRHURCZUJP-CIUDSAMLSA-N 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- JBIRFLWXWDSDTR-CYDGBPFRSA-N Arg-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCN=C(N)N)N JBIRFLWXWDSDTR-CYDGBPFRSA-N 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- FAUPLTGRUBTXNU-FXQIFTODSA-N Asp-Pro-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O FAUPLTGRUBTXNU-FXQIFTODSA-N 0.000 description 1
- FIAKNCXQFFKSSI-ZLUOBGJFSA-N Asp-Ser-Cys Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(O)=O FIAKNCXQFFKSSI-ZLUOBGJFSA-N 0.000 description 1
- ZQFZEBRNAMXXJV-KKUMJFAQSA-N Asp-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O ZQFZEBRNAMXXJV-KKUMJFAQSA-N 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 241001414720 Cicadellidae Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- GUKYYUFHWYRMEU-WHFBIAKZSA-N Cys-Gly-Asp Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O GUKYYUFHWYRMEU-WHFBIAKZSA-N 0.000 description 1
- HBHMVBGGHDMPBF-GARJFASQSA-N Cys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CS)N HBHMVBGGHDMPBF-GARJFASQSA-N 0.000 description 1
- ZOKPRHVIFAUJPV-GUBZILKMSA-N Cys-Pro-Arg Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CS)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O ZOKPRHVIFAUJPV-GUBZILKMSA-N 0.000 description 1
- DRXOWZZHCSBUOI-YJRXYDGGSA-N Cys-Thr-Tyr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CS)N)O DRXOWZZHCSBUOI-YJRXYDGGSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001466042 Fulgoromorpha Species 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- SKOKHBGDXGTDDP-MELADBBJSA-N His-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N SKOKHBGDXGTDDP-MELADBBJSA-N 0.000 description 1
- JTBFQNHKNRZJDS-SYWGBEHUSA-N Ile-Trp-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)O)N JTBFQNHKNRZJDS-SYWGBEHUSA-N 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 1
- OGCQGUIWMSBHRZ-CIUDSAMLSA-N Leu-Asn-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OGCQGUIWMSBHRZ-CIUDSAMLSA-N 0.000 description 1
- PWPBLZXWFXJFHE-RHYQMDGZSA-N Leu-Pro-Thr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O PWPBLZXWFXJFHE-RHYQMDGZSA-N 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- ITUDDXVFGFEKPD-NAKRPEOUSA-N Pro-Ser-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ITUDDXVFGFEKPD-NAKRPEOUSA-N 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- BQWCDDAISCPDQV-XHNCKOQMSA-N Ser-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N)C(=O)O BQWCDDAISCPDQV-XHNCKOQMSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- CTONFVDJYCAMQM-IUKAMOBKSA-N Thr-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)N CTONFVDJYCAMQM-IUKAMOBKSA-N 0.000 description 1
- APIDTRXFGYOLLH-VQVTYTSYSA-N Thr-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)[C@@H](C)O APIDTRXFGYOLLH-VQVTYTSYSA-N 0.000 description 1
- 241001414989 Thysanoptera Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- XKKBFNPJFZLTMY-CWRNSKLLSA-N Trp-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N)C(=O)O XKKBFNPJFZLTMY-CWRNSKLLSA-N 0.000 description 1
- GHUNBABNQPIETG-MELADBBJSA-N Tyr-Cys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CS)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O GHUNBABNQPIETG-MELADBBJSA-N 0.000 description 1
- IWRMTNJCCMEBEX-AVGNSLFASA-N Tyr-Glu-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N)O IWRMTNJCCMEBEX-AVGNSLFASA-N 0.000 description 1
- 230000001188 anti-phage Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 231100000613 environmental toxicology Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 108010079317 prolyl-tyrosine Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
- G01N2430/10—Insecticides
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明属于生物技术领域,涉及具有与氯噻啉抗体特异性结合的多肽,包括所述多肽在检测氯噻啉中的应用。本发明采用噬菌体展示技术,用蛋白A柱纯化的氯噻啉抗体对噬菌体展示随机环七肽库、环八肽库、线十二肽库进行3轮淘选,淘选出与氯噻啉抗体结合的噬菌体克隆;随机挑取若干噬菌体克隆进行扩增和质粒提取,通过噬菌体ELISA方法选择阳性噬菌体克隆,并将阳性克隆进行测序获得多肽序列。本发明还涉及该噬菌体展示多肽在氯噻啉检测中的应用。用该噬菌体展示多肽建立的噬菌体酶联免疫分析方法可用于快速、灵敏、简便和廉价检测环境和农产品中氯噻啉残留。
Description
技术领域
本发明属于生物技术领域,涉及具有与氯噻啉抗体特异性结合的多肽,包括所述多肽在检测氯噻啉中的应用。
背景技术
氯噻啉(imidaclothiz)是南通江山农药化工股份有限公司研发的新型烟碱类杀虫剂。可用于防治吮吸式口器害虫,如蚜虫、叶蝉、飞虱、蓟马、粉虱及其抗性品系,同时对鞘翅目、双翅目和鳞翅目害虫也有防效,尤其对水稻二化螟、三化螟毒力比其它烟碱类杀虫剂高,广泛应用于水稻、小麦、蔬菜、烟草、棉花、果树、茶树等作物,具有高效、广谱等优点。为预防氯噻啉应用存在的潜在风险,需要一种灵敏、快速、选择性的残留检测方法。
目前,对氯噻啉的残留检测包括仪器分析方法和免疫分析法。免疫检测方法具有快速、廉价、简便、灵敏、特异的优点,在大量样品快速筛选和现场监测中显示出独特优势。由于农药等小分子化学品(包括氯噻啉)为单抗原决定簇分析物,整个分子只能和一个抗体结合,所以通常选择竞争模式来建立免疫分析方法。在竞争模式的免疫分析方法中,必须存在一个经过标记的竞争物,通常是将半抗原与蛋白、酶或荧光物等连接制备获得。根据竞争物与免疫抗原结构的同异,可以将分析方法分为同源和异源免疫分析,在之前的大量研究中显示,异源免疫分析的敏感性要远远优于同源免疫分析。敏感性是评价一种检测方法优劣的重要参数,同时高敏感性是免疫分析技术在样品处理过程中选择快速的稀释样品方法的前提条件。但是系列异源半抗原的化学合成及半抗原与蛋白、酶或荧光物等的连接需要很大的工作量。因此,已报道的氯噻啉的免疫分析都为同源免疫分析。
自从噬菌体展示技术第一次报道至今,已经作为一种强大的工具运用在不同的研究中,包括筛选抗体和酶的配体;筛选小分子的受体;抗体工程等。其原理是将多肽或蛋白质的编码基因或目的基因片段克隆入噬菌体外壳蛋白结构基因的适当位置,在阅读框正确且不影响其他外壳蛋白正常功能的情况下,使外源多肽或蛋白与外壳蛋白融合表达,融合蛋白随子代噬菌体的重新组装而展示在噬菌体表面。被展示的多肽或蛋白可以保持相对独立的空间结构和生物活性,以利于靶分子的识别和结合。利用抗体对噬菌体展示随机多肽库进行亲和淘选,可筛选出能够和抗体结合的噬菌体展示多肽。由于筛选出的多肽连接在噬菌体外壳蛋白上,并且抗噬菌体的二抗已商品化,所以筛选出的噬菌体展示多肽不需要与蛋白、酶或荧光物等连接,可直接用作竞争物建立异源竞争免疫分析。与化学合成竞争物相比,从噬菌体展示随机多肽库中淘选竞争物具有操作简单、候选竞争物多、易于制备高质量的竞争物。同时,噬菌体展示多肽竞争物还具有无毒、容易大量制备和纯化的优点。但目前为止,尚未见具有与氯噻啉抗体特异性结合的多肽及其应用的研究和报道。
发明内容
本发明的目的是提供与氯噻啉抗体特异性结合的多肽,及相关多肽在氯噻啉检测中的应用。
本发明的目的通过下述技术方案予以实现:
(1)将蛋白A柱纯化的氯噻啉抗体包被在酶标板上,用5%milk封闭酶标板,将噬菌体展示随机环七肽库、环八肽库、线十二肽库加入包被和封闭后的酶标板中进行亲和淘选,淘选过程按照“吸附-洗涤-洗脱-扩增”的循环进行,一般经过3轮的淘选,每轮淘选降低用于竞争洗脱的氯噻啉的含量;
(2)3轮淘选后,挑选114个噬菌体克隆进行ELISA初步鉴定,85个阳性克隆进行扩增、质粒提取、测序,共发现6种序列,其序列如SEQ ID NO 1~6所示:Cys Pro Arg Ile TrpAla Asp Ser Cys,Cys Thr Tyr Leu Asn Ser Ala Lys Cys,Cys Leu Pro Pro Arg MetIle Tyr Glu Cys,Ser Gln Pro Trp Cys Pro Pro Ser Ile Cys Gly Asp,Thr Met HisLeu Pro Tyr Cys Pro Thr Asn Ile Cys,Asp Tyr His Asp Pro Ser Leu Pro Thr LeuArg Lys。
本发明所述的多肽可与氯噻啉抗体组合,建立异源竞争ELISA,用于氯噻啉在环境与农产品中的残留检测。
本发明具有以下有益效果:(1)新颖:与氯噻啉抗体特异性结合的多肽为国内外首次报道;(2)实用:利用本发明提供的噬菌体展示多肽可以快速建立高敏感性的异源竞争ELISA;(3)特异性强:利用本发明提供的噬菌体展示多肽实现的竞争ELISA与氯噻啉类似物的交叉反应,除吡虫啉(90.42%)外,均小于1.7%;(4)准确度高:利用本发明提供的噬菌体展示多肽实现的竞争ELISA在农产品中的添加回收率为72.3-101.3%,变异系数低于9.4%,符合残留分析标准;(5)灵敏度高:利用本发明提供的噬菌体展示多肽实现的竞争ELISA的抑制中浓度(IC50)为1.45ng/mL,检测限(IC10,LOD)为0.55ng/mL。
附图说明
图1是挑选的114个噬菌体克隆P-ELISA检测的结果;横坐标为噬菌体克隆,纵坐标为OD450值;
图2是竞争P-ELISA检测氯噻啉,OD值与氯噻啉浓度的曲线;横坐标为氯噻啉的浓度,单位为ng/mL;纵坐标为OD450值。
具体实施方式
本发明实施例中所用实验材料、主要试剂及配方如下:
主要实验材料:
蛋白A柱纯化氯噻啉单克隆抗体由南京农业大学,植物保护学院,农药残留与环境毒理实验室制备;噬菌体展示随机环七肽库和线十二肽库从NEB公司购买,噬菌体展示随机环八肽库由美国加州大学-戴维斯分校,Hammock实验室提供。
主要试剂:
蛋白胨(OXOID)、酵母提取物(OXOID)、琼脂(Amresco)、琼脂糖(Amresco)、四甲基联苯胺(Sigma)、IPTG(Amresco)、Xgal(Amresco)、PEG8000(Sigma)、辣根过氧化物酶标记的抗M13单克隆抗体(GE)
主要试剂配方:
1、LB培养基:每升含10g蛋白胨,5g酵母提取物,5g NaCl,高压灭菌,室温贮存;
2、LB/IPTG/Xgal平板:LB培养基+15g/L琼脂粉。高压灭菌,冷却至低于70℃时,加入1mL IPTG/Xgal,混匀倒平板。平板4℃避光贮存;
3、顶层琼脂:每升含10g蛋白胨,5g酵母提取物,5g NaCl,7g琼脂粉。高压灭菌,固体培养基室温贮存,用时微波炉融化;
4、四环素贮液:以20mg/mL的浓度溶于50%乙醇中,-20℃避光贮存,用前摇匀;
5、LB-Tet平板:LB培养基+15g/L琼脂粉。高压灭菌,冷却至低于70℃时,加入1mL四环素贮液,混匀倒平板,平板4℃避光贮存;
6、封闭液:含有3%BSA,0.15M,pH 7.4PBS,过滤除菌,4℃保存;
7、PEG/NaCl:20%(w/v)PEG-8000,2.5M NaCl,高压灭菌,室温贮存;
8、IPTG/Xgal配方:将1.25g IPTG(isopropylβ-D-thiogalactoside)和1g Xgal溶于25mL二甲基甲酰胺中,-20℃避光贮存;
9、显色液(四甲基联苯胺-H2O2底物溶液):25mL 0.1M,pH 5.5柠檬酸盐缓冲液中加入0.4mL,6mg/mL四甲基联苯胺,0.1mL 1%H2O2。
实施例1氯噻啉抗体特异性结合多肽的淘选和制备
1、与氯噻啉抗体特异性结合的噬菌体克隆的淘选
按照“吸附-洗涤-洗脱-扩增”的循环进行,经过3轮的淘选,具体操作如下:
(1)取100μL 75μg/mL蛋白A柱纯化的氯噻啉抗体加入酶标板中,4℃包被过夜,共三个孔;
(2)取少量大肠杆菌ER2738涂在LB+Tet平板上,37℃过夜培养;
(3)将步骤(1)的酶标板用PBST洗涤5遍,加入300μL 5%milk,37℃孵育2小时,用PBST洗涤5遍,存放于4℃备用;
(4)将酶标板每孔加入100μL 2×1011的噬菌体(含3%milk),室温轻微震荡1小时;
(5)取20mL LB培养基加入250mL三角瓶中,加入ER2738单菌落,37℃培养至OD600为0.01至0.05;
(6)将步骤(4)的微孔用PBST洗涤10遍,加入100μL 2μg/mL的氯噻啉进行洗脱,室温轻微震荡1小时;
(7)收集步骤(6)中的洗脱缓冲液,加入5%milk包被的孔,室温轻微震荡1小时,去除非特异性结合。收集上清液,4℃保存;
(8)取少量脱液测定噬菌体的滴度(操作方法见滴度测定);
(9)剩余的洗脱缓冲液用于扩增,将剩余的洗脱缓冲液加入步骤(5)中的三角瓶中,37℃摇床培养4至4.5小时;
(10)将扩增的噬菌体移入50mL的离心管中,4℃12000g离心10分钟,取上清。重复离心一次;
(11)取上层80%的上清放入离心管中,加入上清1/6体积的20%PEG-8000/2.5MNaCl,混匀,4℃静置过夜;
(12)将(11)步骤的混合液4℃12000g离心15分钟,去上清,重复一次;
(13)取400μL PBS溶解步骤(12)的沉淀物用于下一轮的淘选,也可放于4℃短期(大约三周不会影响滴度)保存,或者加入甘油,放于-20℃长期保存;
(14)步骤(1)到(13)为一轮淘选和扩增,第二轮和第三轮的淘选和扩增步骤同上,步骤(1)中使用的氯噻啉抗体浓度分别为50μg/mL和25μg/mL,步骤(6)中使用的氯噻啉浓度分别为0.5μg/mL和0.1μg/mL,
噬菌体滴度测定操作步骤如下:
(1)取4mL LB培养基,加入20μL 50mg/mL的四环素,取大肠杆菌ER2738单菌落加入其中,37℃培养至OD600为0.5;
(2)将LB/IPTG/Xgal平板放入37℃培养箱中预热1小时以上;
(3)取5mL融化的顶层琼脂(LB+7g/L琼脂糖)放入离心管中,并保持离心管在45℃;
(4)将需要测滴度的噬菌体进行稀释,通常洗脱缓冲液稀释10至103倍,扩增之后的噬菌体稀释108至1011;
(5)取10μL稀释后的噬菌体加入到180μL步骤(1)的大肠杆菌培养液中,混匀;
(6)将步骤(5)的混合液加入步骤(3)中的顶层琼脂中,混匀;
(7)将步骤(6)的混合液均匀的加入到步骤(2)中的平板上,室温冷却,放入37℃培养箱中过夜培养;
(8)根据平板上蓝色斑点的数量来计算所测噬菌体的滴度。
整个淘选过程的洗脱噬菌体和扩增后的噬菌体的个数如表1所示。
表1与氯噻啉抗体结合的噬菌体展示多肽淘选情况(环七肽库)
表2与氯噻啉抗体结合的噬菌体展示多肽淘选情况(环八肽库)
表2与氯噻啉抗体结合的噬菌体展示多肽淘选情况(线十二肽库)
2、噬菌体克隆的筛选及其展示多肽序列的测定
在完成最后一次淘选之后,对洗脱液进行滴度测定,选择蓝色斑点少于100个的LB/IPTG/Xgal平板,从中挑选出114个克隆用于扩增和鉴定。操作程序如下:
(1)用LB培养液将过夜培养的大肠杆菌ER2738以1∶100稀释,并以5mL每试管分散在48个试管中;
(2)从LB/IPTG/Xgal平板挑选出48个克隆放入试管中,37℃摇床培养4.5至5小时;
(3)将培养液4℃12000g离心10分钟,上清用于噬菌体酶联免疫分析(P-ELISA)验证(操作方法见P-ELISA),沉淀用质粒提取试剂盒提取质粒,送测序公司进行序列测定。
噬菌体酶联免疫分析操作步骤:
(1)包被:用PBS缓冲液将氯噻啉抗体稀释后加入酶标板,每孔100μl,4℃孵育过夜;
(2)洗板:用洗涤液PBST(0.05%吐温20,0.01mol/L,pH 7.4)洗涤5次,吸水纸拍干;
(3)封闭:每孔加入300μL 3%milk,37℃孵育2小时;
(4)洗板:同(2);
(5)加入分析物和噬菌体:每孔加入50μL PBS或50μL 10μg/mL氯噻啉溶液,再加入50μL的噬菌体展示多肽,室温轻微震荡1小时,PBST洗涤5次,并平行设置阴性对照。
(6)洗板:同(2);
(7)加入酶标二抗体:每孔加入100μL经1∶5000倍PBST稀释的辣根过氧化物酶标记的抗M13单克隆抗体,室温轻微震荡1小时;
(8)洗板:同(2);
(9)显色:每孔加入100μL新鲜配制的显色液,37℃温箱孵育15分钟;
(10)终止:每孔加50μL 2mol/L的H2SO4溶液;
(11)吸光度测定:用酶标仪测定450nm波长处的各孔吸光值。
挑选的114个噬菌体克隆中85个克隆在P-ELISA检测时有或无氯噻啉的OD450值存在显著差异(图1)。将上述85个克隆的质粒送金斯瑞生物科技有限公司测序,测序引物为5’-CCCTCATAGTTAGCGTAACG-3’。测序结果共发现6种序列,其序列如表2中SEQ ID NO 1~6所示。
表2噬菌体展示多肽的氨基酸序列
3、P-ELISA对氯噻啉的检测
3.1方法原理
采用间接竞争免疫分析方法。将氯噻啉抗体吸附于固相载体(96孔酶标板)上,制备成固相抗体,然后加入待测样品和噬菌体展示多肽。噬菌体展示多肽和待测样品中的氯噻啉与固相抗体进行竞争结合反应,待测农药含量多,被结合在固相抗体上的噬菌体少,反之结合在固相抗体的噬菌体多,反应后加入辣根过氧化物酶标记的抗M13单克隆抗体(只能与结合在固相抗体上的噬菌体结合),最后用底物进行显色加以测定。被结合在固相抗体上的噬菌体少,显色弱,OD450值低,反之,则显色强,OD450值高,因而可根据已知量农药的标准曲线和待检样品的OD450值,推算出待测农药的浓度。
3.2抗体和噬菌体展示多肽的工作浓度
P-ELISA抗体和噬菌体展示多肽工作浓度的确定用方阵滴定法,选择OD值为1.0~2.0时的浓度。经实验,抗体5μg/mL、SEQ ID NO 5噬菌体2.5×108pfu/mL为最适工作浓度。
3.3 P-ELISA程序
(1)包被:用PBS缓冲液将氯噻啉抗体稀释至5μg/mL加入酶标板,每孔100μl,4℃孵育过夜;
(2)洗板:用洗涤液PBST(0.05%吐温20,0.01mol/L,pH 7.4)洗涤5次,吸水纸拍干;
(3)封闭:每孔加入300μL 3%milk,37℃孵育2小时;
(4)洗板:同(2);
(5)加入分析物和噬菌体:每孔加入50μL待测样品,再加入50μL,5×108pfu/mL的噬菌体展示多肽,室温轻微震荡1小时,PBST洗涤5次,并平行设置阳性对照和阴性对照。
(6)洗板:同(2);
(7)加入酶标二抗体:每孔加入100μL经1∶5000倍PBST稀释的辣根过氧化物酶标记的抗M13单克隆抗体,室温轻微震荡1小时;
(8)洗板:同(2);
(9)显色:每孔加入100μL新鲜配制的显色液,37℃温箱孵育15分钟;
(10)终止:每孔加50μL 2mol/L的H2SO4溶液;
(11)吸光度测定:用酶标仪测定450nm波长处的各孔吸光值。
3.4标准曲线和灵敏度
根据OD450值与氯噻啉浓度作图即得到标准曲线(图2),计算抑制中浓度(IC50)及最低检测限(IC10,LOD)分别为1.45ng/mL,LOD为0.55ng/mL。
3.5特异性
常用交叉反应率作为评价的重要标准。交叉反应率越小,检测方法的特异性越好。P-ELISA除与吡虫啉有交叉反应外(CR%=90.4%),与其它新烟碱类杀虫剂没有明显的交叉反应(CR%小于或等于1.7%)。从而可知,所制备的噬菌体展示多肽,可以用于特异性的检测氯噻啉。
3.6样品添加检测
3.6.1样品处理
称取粉碎混匀后的甘蓝、大米、苹果、青菜、梨、番茄和土壤样品10g,装入50mL离心管中,加入20mL含50%甲醇的PBS缓冲液混匀,涡旋3min,超声15min,4000rpm离心5min,将上清全部转移至25mL容量瓶内,用PBS缓冲液定容至25mL。再用PBS缓冲液稀释32倍用于检测。
3.6.2样品检测
样品检测步骤参考3.3。经分析可知,该P-ELISA的氯噻啉回收率为72.3-101.3%,相对标准偏差为1.4-9.4%。
实际样品中氯噻啉残留量检测参照3.6方法进行。
本发明建立的氯噻啉P-ELISA方法符合氯噻啉残留分析标准。该方法可用于环境和农产品中氯噻啉的残留检测,且前处理方法较仪器分析方法简单,适合大批量检测和现场监测。
Claims (3)
1.具有与氯噻啉抗体特异性结合的多肽,其特征在于,所述多肽具有SEQ ID NO:1~6的氨基酸序列。
2.根据权利要求1和2所述具有与氯噻啉抗体特异性结合的多肽,其特征在于,通过GGGS连接在M13噬菌体外壳蛋白上。
3.权利要求1具有与氯噻啉抗体特异性结合的多肽在检测氯噻啉中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611271306.6A CN106749527A (zh) | 2016-12-28 | 2016-12-28 | 氯噻啉抗体特异性结合的噬菌体展示多肽及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611271306.6A CN106749527A (zh) | 2016-12-28 | 2016-12-28 | 氯噻啉抗体特异性结合的噬菌体展示多肽及其用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106749527A true CN106749527A (zh) | 2017-05-31 |
Family
ID=58951948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611271306.6A Pending CN106749527A (zh) | 2016-12-28 | 2016-12-28 | 氯噻啉抗体特异性结合的噬菌体展示多肽及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106749527A (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108409836A (zh) * | 2018-01-08 | 2018-08-17 | 中国医科大学 | 一种多肽及其用途 |
CN108530520A (zh) * | 2018-04-19 | 2018-09-14 | 福建师范大学福清分校 | 一种锰离子结合肽及其筛选方法、亲和性能的检测方法 |
WO2019119302A1 (zh) * | 2017-12-20 | 2019-06-27 | 深圳先进技术研究院 | 一种cmklr1拮抗多肽及其衍生物与应用 |
CN109942682A (zh) * | 2017-12-20 | 2019-06-28 | 深圳先进技术研究院 | 一种cmklr1拮抗多肽及其衍生物与应用 |
CN109942679A (zh) * | 2017-12-19 | 2019-06-28 | 深圳先进技术研究院 | 一种gpr1拮抗多肽及其衍生物与应用 |
CN110567929A (zh) * | 2019-05-08 | 2019-12-13 | 南京农业大学 | 一种氯噻啉的双信号侧流免疫层析检测方法 |
CN110627872A (zh) * | 2019-05-08 | 2019-12-31 | 南京农业大学 | 吡虫啉抗体特异性结合的噬菌体展示多肽及其用途 |
US20220119451A1 (en) * | 2020-10-21 | 2022-04-21 | Kun Cheng | Polypeptides And Compositions Comprising The Same |
US12258424B2 (en) * | 2021-10-21 | 2025-03-25 | Polypeptides and compositions comprising the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104974256A (zh) * | 2015-04-10 | 2015-10-14 | 南京农业大学 | 一种抗噻虫啉单克隆抗体及其用途 |
CN110256531A (zh) * | 2019-05-08 | 2019-09-20 | 南京农业大学 | 吡虫啉抗体特异性结合的噬菌体展示多肽及其用途 |
-
2016
- 2016-12-28 CN CN201611271306.6A patent/CN106749527A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104974256A (zh) * | 2015-04-10 | 2015-10-14 | 南京农业大学 | 一种抗噻虫啉单克隆抗体及其用途 |
CN110256531A (zh) * | 2019-05-08 | 2019-09-20 | 南京农业大学 | 吡虫啉抗体特异性结合的噬菌体展示多肽及其用途 |
Non-Patent Citations (2)
Title |
---|
YUAN DING: "Development of a phage cheenvironmental samplesmiluminescent enzyme immunoassay with high sensitivity for the determination of imidaclothiz in agricultural and", 《SCIENCE OF THE TOTAL ENVIRONMENT》 * |
方松: "氯噻啉酶联免疫分析方法研究", 《农药学学报》 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109942679A (zh) * | 2017-12-19 | 2019-06-28 | 深圳先进技术研究院 | 一种gpr1拮抗多肽及其衍生物与应用 |
CN109942679B (zh) * | 2017-12-19 | 2021-04-23 | 深圳先进技术研究院 | 一种gpr1拮抗多肽及其衍生物与应用 |
CN109942682B (zh) * | 2017-12-20 | 2021-06-18 | 深圳先进技术研究院 | 一种cmklr1拮抗多肽及其衍生物与应用 |
WO2019119302A1 (zh) * | 2017-12-20 | 2019-06-27 | 深圳先进技术研究院 | 一种cmklr1拮抗多肽及其衍生物与应用 |
CN109942682A (zh) * | 2017-12-20 | 2019-06-28 | 深圳先进技术研究院 | 一种cmklr1拮抗多肽及其衍生物与应用 |
CN108409836B (zh) * | 2018-01-08 | 2020-04-21 | 中国医科大学 | 一种多肽及其用途 |
WO2019134392A1 (zh) * | 2018-01-08 | 2019-07-11 | 中国医科大学 | 一种多肽及其用途 |
CN108409836A (zh) * | 2018-01-08 | 2018-08-17 | 中国医科大学 | 一种多肽及其用途 |
CN108530520B (zh) * | 2018-04-19 | 2021-02-19 | 福建师范大学福清分校 | 一种锰离子结合肽及其筛选方法、亲和性能的检测方法 |
CN108530520A (zh) * | 2018-04-19 | 2018-09-14 | 福建师范大学福清分校 | 一种锰离子结合肽及其筛选方法、亲和性能的检测方法 |
CN110627872A (zh) * | 2019-05-08 | 2019-12-31 | 南京农业大学 | 吡虫啉抗体特异性结合的噬菌体展示多肽及其用途 |
CN110567929A (zh) * | 2019-05-08 | 2019-12-13 | 南京农业大学 | 一种氯噻啉的双信号侧流免疫层析检测方法 |
US20220119451A1 (en) * | 2020-10-21 | 2022-04-21 | Kun Cheng | Polypeptides And Compositions Comprising The Same |
US12258424B2 (en) * | 2021-10-21 | 2025-03-25 | Polypeptides and compositions comprising the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106749527A (zh) | 氯噻啉抗体特异性结合的噬菌体展示多肽及其用途 | |
Goldman et al. | Selection of phage displayed peptides for the detection of 2, 4, 6-trinitrotoluene in seawater | |
CN106680484B (zh) | 分析甲萘威残留的elisa检测试剂盒及其应用 | |
CN110627872A (zh) | 吡虫啉抗体特异性结合的噬菌体展示多肽及其用途 | |
CN113388037B (zh) | 一种特异性识别杀螟硫磷纳米抗体的制备及其应用 | |
CN105153280B (zh) | 苯噻菌酯免疫复合体特异性结合的多肽及其用途 | |
CN113461782B (zh) | 孔雀石绿的抗原模拟表位、制备方法及其应用 | |
CN104987361B (zh) | 苯噻菌酯抗体特异性结合的多肽及其用途 | |
Mertens et al. | Selection of phage-displayed peptides recognised by monoclonal antibodies directed against the lipopolysaccharide of Brucella | |
CN107056946A (zh) | 一种抗二乙氧基硫代磷酸酯类有机磷农药的Fab抗体及制备方法和应用 | |
CN110684080A (zh) | 一种适用于噻虫嗪残留分析的scFv-ELISA试剂盒 | |
CN113754762B (zh) | 一种抗Cry3Bb蛋白单域重链抗体及其应用 | |
CN112920277B (zh) | 分析溴氰虫酰胺和氯虫苯甲酰胺残留的vhh-elisa试剂盒及其应用 | |
CN114702592B (zh) | 一种识别喹硫磷农药的纳米抗体及酶联免疫分析方法 | |
CN107817341B (zh) | 基于纳米抗体检测三唑磷残留的elisa试剂盒及其应用 | |
CN114989257A (zh) | 金刚烷胺抗原模拟表位及其在磁微粒酶促化学发光均相免疫检测方法中的应用 | |
CN104530194A (zh) | 针对赭曲霉毒素a的抗原模拟表位及其应用 | |
CN104327166B (zh) | 赭曲霉毒素a的十二肽抗原模拟表位及其应用 | |
CN107417790B (zh) | 一种适用于三唑磷残留分析的vhh-elisa试剂盒 | |
CN114634550B (zh) | 一种河豚毒素的非诊断目的检测方法 | |
CN114085267B (zh) | 一种检测氨基甲酸乙酯的方法 | |
CN114230632B (zh) | 一种丙烯酰胺衍生物模拟表位肽及应用 | |
CN104311634B (zh) | 黄曲霉毒素b1的抗原模拟表位am‑1及其应用 | |
CN104530195B (zh) | 模拟赭曲霉毒素a的抗原模拟表位及其应用 | |
CN110294790B (zh) | Cry1Da蛋白的多肽配体分子及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170531 |